Palisade Bio Inc
7NS0
Company Profile
Business description
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Contact
7750 El Camino Real
Suite 2A
CarlsbadCA92009
USAT: +1 858 704-4900
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
8
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,021.90 | 60.20 | 0.76% |
| CAC 40 | 7,285.86 | 44.11 | -0.60% |
| DAX 40 | 21,205.86 | 105.16 | -0.49% |
| Dow JONES (US) | 37,982.88 | 1,159.35 | -2.96% |
| FTSE 100 | 8,275.66 | 0.06 | 0.00% |
| HKSE | 21,395.14 | 338.16 | 1.61% |
| NASDAQ | 15,728.06 | 558.39 | -3.43% |
| Nikkei 225 | 34,279.92 | 450.36 | -1.30% |
| NZX 50 Index | 12,118.99 | 51.07 | 0.42% |
| S&P 500 | 5,116.05 | 166.65 | -3.15% |
| S&P/ASX 200 | 7,819.10 | 60.20 | 0.78% |
| SSE Composite Index | 3,280.34 | 4.34 | 0.13% |